Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-12

Clinical Trial Update: Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluated the efficacy and safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel for acne vulgaris; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel (adapalene/benzoyl peroxide)

Snippet

Sponsor: Galderma Brasil Ltda. | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED